发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 108 |
| Canada | 18 |
| Netherlands | 16 |
| England | 14 |
| GERMANY (FED REP GER) | 9 |
| France | 6 |
| Italy | 5 |
| Spain | 5 |
| Sweden | 5 |
| Austria | 4 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| MEM HEALTHCARE SYST | 14 |
| UNIVERSITY OF TEXAS SYSTEM | 14 |
| UNIVERSITY OF ROCHESTER | 12 |
| CORNELL UNIVERSITY | 10 |
| UNIVERSITY OF CHICAGO | 8 |
| UNIVERSITY OF BIRMINGHAM | 7 |
| UNIVERSITY OF WASHINGTON | 7 |
| BAYLOR COLLEGE OF MEDICINE | 6 |
| FRED HUTCHINSON CANCER CENTER | 6 |
| NORTHWESTERN UNIVERSITY | 6 |
文章引用情况
1
Evaluation of Hematuria in a Large Public Health Care System2
Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers3
Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer4
Venous Thromboembolism and Pefi-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study5
Bladder Cancer Multidisciplinary Clinic (BCMC) Model Influences Disease Assessment and Impacts Treatment Recommendations6
Modeling Tumor Heterogeneity in Bladder Cancer: The Current State of the Field and Future Needs7
Assessment of a European Bladder Cancer Predictive Model for Non-Muscle Invasive Bladder Cancer in an Australian Cohort8
Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention9
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E Qapzola (TM)) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer10
Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer